Mark Floyd Lew, MD

Professor of Clinical Neurology

Joseph P. Van Der Meulen, M.D. Chair in Parkinson's Disease Research in Honor of Robert J. Pasarow

Vice Chair, Department of Neurology

Division Chief, Movement Disorders

Is this your profile? Click to edit

Overview

Dr. Lew has an international reputation for the treatment of patients with Parkinson’s disease, dystonia, and other movement disorders. He is a board certified neurologist and a fellow of the American Academy of Neurology. Dr. Lew is the director of the Division of Movement Disorders and serves as the vice chairman of the Department of Neurology. He has lectured extensively in the United States and abroad on clinical research related to new therapies for Parkinson’s disease and dystonia. Dr. Lew also collaborates closely with local and national advocacy organizations (e.g., the Hollyrod Foundation and the National Parkinson’s Foundation) to increase public awareness and to support research and care.

Research Funding

Neuroprotective Clinical Studies in Parkinson's Disease
NIH · U10NS044462 · Sep 15, 2002 – Nov 30, 2015 · Role: Principal Investigator

Publications

Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome). Mov Disord. 1994 May; 9(3):318-20.. View in PubMed
Clozapine treatment of parkinsonism with psychosis. J Am Geriatr Soc. 1993 Jun; 41(6):669-71.. View in PubMed
Consciousness, coma, and the vegetative state: physical basis and definitional character. Issues Law Med. 1991; 6(4):361-71.. View in PubMed

Mark Floyd Lew, MD

Overview

Research Funding

Publications

Similar People